Meanwhile, miR-145 is downregulated in certain cancers, including colon cancer9, breast cancer10, and lung cancer11, and it targets oncogenes such as MYC, MUC1, and OCT4 to limit cancer development. The gene discussed is MUC1; the disease is cancer.